Some might not follow the best practices, leading them to produce drugs that dont work well or arent safe
Here is what Novo Nordisk's defense teams have generally argued: The Label Already Warned of GI Risks Novo Nordisk points to the existing Ozempic FDA label, which does warn of nausea, vomiting, diarrhea, and abdominal pain
Three studies were conducted in the United States, and two studies were conducted in Ukraine and Italy
10.1007/s11481-018-9824-3 88 MushtaqA.LiL.AA.GrNDAHLL
As a result of obesity, insulin resistance, hypertension, and dyslipidemia can develop, as well as complications such as type 2 diabetes, cardiovascular disease, and nonalcoholic fatty liver disease
The distribution of studies and potential biomarkers analyzed by country was as follows: Brazil, 6 studies and 11 biomarkers